Clinical follow up of pathological gambling in Parkinson's disease in the West Scotland study

Movement Disorders

Volumn 24, Issue 16, 2009, Pages 2430-2431

  Macphee, Graeme J A ^a   Copeland, Claire ^a   Stewart, David ^b   Grosset, Katherine ^a   Grosset, Donald G ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA;

AGE DISTRIBUTION; DISEASE DURATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; DYSPHORIA; FOLLOW UP; HUMAN; IMPULSE CONTROL DISORDER; LETTER; MOOD DISORDER; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; REMISSION; SEX DIFFERENCE; UNITED KINGDOM;

DOPAMINE AGENTS; FOLLOW-UP STUDIES; GAMBLING; HUMANS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SCOTLAND;

EID: 73949119444     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22824     Document Type: Letter

References (3)

1. Grosset KA, Macphee G, Pal G. Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006;21:2206-2208.
2. Mamikonyan E, Siderowf A, Duda JE. Long term follow up of impulse control disorders in Parkinson's disease. Mov Disord 2008;23:75-80.
3. Gallagher DA, O'Sullivan SS, Evans AH. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22:1757-1763.